Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin pill following oral administration to mice. (23rd February 2015)
- Record Type:
- Journal Article
- Title:
- Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin pill following oral administration to mice. (23rd February 2015)
- Main Title:
- Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin pill following oral administration to mice
- Authors:
- Huang, Huimei
Yang, Yongge
Lv, Chao
Chang, Wanlin
Peng, Chengcheng
Wang, Shuping
Ge, Guangbo
Han, Lin
Zhang, Weidong
Liu, Runhui - Abstract:
- Abstract: Ethnopharmacological relevance: Shexiang Baoxin Pill (SBP) is a well-known composite formula of traditional Chinese medicine (TCM), widely used to treat cardiovascular diseases such as angina pectoris and myocardial infarction. Bufadienolides are major active compounds of Venenum Bufonis, which is one of the seven materiamedicas that comprise the Shexiang Baoxin Pill. Previous pharmacokinetics studies of bufadienolides have typically used a single medicinal material delivered to rats. In this study, we have chosen the mouse, a more proper animal model than the rat, to investigate the in vivo pharmacokinetics and tissue distribution of bufadienolides from the Shexiang Baoxin Pill. Materials and methods: The concentrations of bufadienolides in plasma and tissues were identified using high performance liquid chromatography–tandem mass spectrometry (HPLC–ESI-MS/MS). The samples were prepared by liquid–liquid extraction with ethyl acetate, and the separation of bufadienolides was achieved using an ACQUITY HSS T3 column by gradient elution using water (containing 0.1% formic acid) and acetonitrile as the mobile phase at a flow rate of 0.3 mL/min. The pharmacokinetic parameters were determined using non-compartmental analysis. Results: The results showed that the five bufadienolides were rapidly absorbed and distributed into the body. The pharmacokinetic curve showed double peaks after oral administration. The major tissue depots for resibufogenin, bufalin, and bufotalinAbstract: Ethnopharmacological relevance: Shexiang Baoxin Pill (SBP) is a well-known composite formula of traditional Chinese medicine (TCM), widely used to treat cardiovascular diseases such as angina pectoris and myocardial infarction. Bufadienolides are major active compounds of Venenum Bufonis, which is one of the seven materiamedicas that comprise the Shexiang Baoxin Pill. Previous pharmacokinetics studies of bufadienolides have typically used a single medicinal material delivered to rats. In this study, we have chosen the mouse, a more proper animal model than the rat, to investigate the in vivo pharmacokinetics and tissue distribution of bufadienolides from the Shexiang Baoxin Pill. Materials and methods: The concentrations of bufadienolides in plasma and tissues were identified using high performance liquid chromatography–tandem mass spectrometry (HPLC–ESI-MS/MS). The samples were prepared by liquid–liquid extraction with ethyl acetate, and the separation of bufadienolides was achieved using an ACQUITY HSS T3 column by gradient elution using water (containing 0.1% formic acid) and acetonitrile as the mobile phase at a flow rate of 0.3 mL/min. The pharmacokinetic parameters were determined using non-compartmental analysis. Results: The results showed that the five bufadienolides were rapidly absorbed and distributed into the body. The pharmacokinetic curve showed double peaks after oral administration. The major tissue depots for resibufogenin, bufalin, and bufotalin in mice were the intestines, lung and kidney, whereas the major tissue depots of gamabufotalin and arenobufagin were the intestines, liver and kidney. Conclusion: The information gained from this research provides a meaningful insight for the clinical applications of the Shexiang Baoxin Pill. Graphical abstract: … (more)
- Is Part Of:
- Journal of ethnopharmacology. Volume 161(2015)
- Journal:
- Journal of ethnopharmacology
- Issue:
- Volume 161(2015)
- Issue Display:
- Volume 161, Issue 2015 (2015)
- Year:
- 2015
- Volume:
- 161
- Issue:
- 2015
- Issue Sort Value:
- 2015-0161-2015-0000
- Page Start:
- 175
- Page End:
- 185
- Publication Date:
- 2015-02-23
- Subjects:
- Resibufogenin (PubChem CID: 10063) -- bufalin (PubChem CID: 9547215) -- gamabufotalin (PubChem CID: 259803) -- arenobufagin (PubChem CID: 10051) -- bufotalin (PubChem CID: 12302120) -- tinidazole (PubChem CID: 5479)
Bufadienolides -- Shexiang Baoxin Pill -- Pharmacokinetic -- Tissue distribution -- LC–ESI-MS/MS
Ethnopharmacology -- Periodicals
Pharmacognosy -- Periodicals
Herbs -- Periodicals
Herbs -- Periodicals
Pharmacognosy -- Periodicals
Pharmacognosie -- Périodiques
Herbes -- Périodiques
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03788741 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jep.2014.07.056 ↗
- Languages:
- English
- ISSNs:
- 0378-8741
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.602400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5769.xml